Unlock the potential of cutting-edge psychedelic research with our comprehensive 3-course bundle on Psilocybin, MDMA, and Ketamine. Designed for mental health professionals, researchers, and anyone interested in the latest clinical insights, this interactive eLearning package provides in-depth lessons on the pharmacology, safety and effects, therapeutic applications, and clinical research of the three most common psychedelic substances.  

What’s Included in this Bundle?
Understanding Psilocybin: Effects, Neurobiology, and Therapeutic Approaches – Learn about the neuroscience behind psilocybin, its effects on the brain, and its potential for treating depression, addiction, and anxiety-related disorders (9 hours of content, regular price is $139 completion or $249 CE, click to view this course page). 

Foundations in MDMA Safety, Therapeutic Applications & Research – Gain insight into clinical protocols, safety considerations, and trial findings related to MDMA’s use in psychotherapy (6 hours of content, regular price is $139 completion or $249 CE; click to view this course page).
 
Ketamine: Therapeutic Applications, Clinical Research, and Neural Mechanisms – Explore ketamine’s dual frameworks: its biomedical applications and its role in psychotherapy for mental health treatment (5 hours of content, regular price is $139 completion or $249 CE, click to view this course page).    

After completing this psychedelic therapy course bundle, health providers will be better equipped to provide accurate, evidence-based information to their patients about psilocybin, ketamine, and MDMA. With insights from experienced practitioners and real-world clinical outcomes, clinicians will be prepared to address patient questions about potential benefits, risks in medical and non-medical settings, and current treatment protocols. 

***Bundle all 3 courses to save 50%***

Foundations in MDMA Safety, Therapeutic Applications & Research 

Module 1: A Simple Molecule with Complex Effects: MDMA Pharmacology, Effects, and Safety

Module 2:  Neurobiological Effects of MDMA: Brain Circuits to Behavior

Module 3: Clinical Trial Findings of MDMA-assisted Psychotherapy for Treatment of PTSD and Other Psychiatric Indications

Module 4: MDMA Therapeutic Approaches and Psychological Mechanisms

Instructors, Speakers, and Panelists:
Allison Feduccia, PhD, Kile Ortigo, PhD, Boris Heifets, MD, PhD, Genesee Herzberg, PsyD, Evan Sola, PsyD, Sylver Quevedo, MD, Sara Garcia Velazquez, MD, Zachary Herrmann, DO, Matthias Liechti, MD, PhD, Jason Luoma, PhD, Gillinder Bedi, DPsych, and Lauren Lepow, MD

Understanding Psilocybin: Effects, Neurobiology, and Therapeutic Approaches

Module 1: What’s All The Magic About? Psilocybin Pharmacology, Effects, and Safety

Module 2: Clinical Trial Findings of Psilocybin Treatment for Depression and Other Psychiatric Indications

Module 3: Psilocybin Ancient History, Psychological Mechanisms, and the Future of Microdosing

Module 4: Neurobiological Effects of Psilocybin: Brain Circuits to Behavior

Instructors, Speakers, and Panelists: 
Allison Feduccia, PhD, Kile Ortigo, PhD, Boris Heifets, MD, PhD, Bill Richards, PhD, Karen Peoples, PhD, Alicia Danforth, PhD, Chris Stauffer, MD, Christopher Nicholas, PhD, Peter Hendricks, PhD, Emmanuelle Schindler, MD, PhD, Katrin Preller, PhD, Lauren Lepow, MD, C.J. Spotswood, BN-RN BC, Zachary Herrmann, DO, and Joshua Poole, MD

Ketamine: Therapeutic Applications, Clinical Research, and Neural Mechanisms 
 

Module 1: Ketamine Pharmacology, Effects, and Safety

Module 2: Ketamine Clinical Applications and Therapeutic Approaches

Instructors, Speakers, and Panelists:
Allison Feduccia, PhD, Kyle Greenway, MD, Genesee Herzberg, PsyD, Kelan Thomas, PharmD, Boris Heifets, MD, PhD, Veronika Gold, LMFT, Eric Sienknecht, PsyD, Harvey Schwartz, PhD, Julie Megler, NP, and Nicholas Garel, MD